SEC Form 4 · accession 0001213900-15-009524
RELMADA THERAPEUTICS, INC. · RLMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sandesh Seth
Director
Period of report
Dec 14, 2015
Accepted (ET)
Dec 16, 2015 · 4:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001553643
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Dec 14, 2015 | P | 800 | $2.50 | A | 104,058 | D | |
| Common stock | Dec 14, 2015 | P | 140 | $2.50 | A | 104,198 | D | |
| Common stock | Dec 14, 2015 | P | 1,560 | $2.89 | A | 105,758 | D | |
| Common stock | Dec 14, 2015 | P | 500 | $2.90 | A | 106,258 | D | |
| Common stock | Dec 14, 2015 | P | 1,000 | $2.97 | A | 107,258 | D | |
| Common stock | Dec 14, 2015 | P | 5,000 | $2.99 | A | 112,258 | D | |
| Common stock | Dec 14, 2015 | P | 1,500 | $3.00 | A | 113,758 | D |
Table II — derivative securities
No Table II lines on this filing.